Ipilimumab/sintilimabAsthma: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1890卷 / 1期

关键词：

D O I：

10.1007/s40278-022-09140-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：143 / 143

相关论文

共 50 条

[21] Ipilimumab/nivolumabNeurosarcoidosis: case report
Reactions Weekly, 2018, 1716 (1) : 170 - 170
[22] Ipilimumab/nivolumabHypopituitarism : case report
Reactions Weekly, 2022, 1907 (1) : 267 - 267
[23] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2019, 1747 (1) : 159 - 159
[24] Ipilimumab/nivolumabAcrocyanosis: case report
Reactions Weekly, 2020, 1833 (1) : 215 - 215
[25] Ipilimumab/nivolumabPneumonitis: case report
Reactions Weekly, 2023, 1967 (1) : 207 - 207
[26] Ipilimumab/NivolumabHepatotoxicity: case report
Reactions Weekly, 2024, 2038 (1) : 168 - 168
[27] Ipilimumab/nivolumabPancytopenia: case report
Reactions Weekly, 2024, 2023 (1) : 212 - 212
[28] Ipilimumab/nivolumabPancreatitis: case report
Reactions Weekly, 2022, 1924 (1) : 259 - 259
[29] Ipilimumab/NivolumabMyocarditis: case report
Reactions Weekly, 2025, 2050 (1) : 284 - 284
[30] Ipilimumab/nivolumabPapilloedema: case report
Reactions Weekly, 2019, 1768 (1) : 198 - 198

← 1 2 3 4 5 →